Intraductal Meibomian Gland Probing (MGP) has now been reported by multiple independent investigators to release gland obstruction, stimulate meibum secretion, and relieve signs and symptoms of obstructive Meibomian Gland Dysfunction (MGD).

Probe findings suggesting internal ductal strictures secondary to periglandular fibrotic obstruction occur in at least 66% of all glands (submitted for publication), and are relieved with MGP, safely restoring integrity to the intraductal space allowing the gland to resume function and, according to some studies, potentially regrow.

After MGP, Meibum Secreting Lid Functionality (MSLF) and number of expressible glands improve. Studies have shown rapid and dramatic reduction of symptoms of obstructive MGD after MGP using Maskin® Probes and the associated protocol.